Simulations Plus Releases GastroPlus™ 5.2
LANCASTER, Calif.–(BUSINESS WIRE)–Simulations Plus, Inc. (AMEX:SLP), a leading provider of simulation and modeling software for pharmaceutical discovery and development, announced that it has released version 5.2 of its flagship GastroPlus™ simulation software product.
Dr. Viera Lukacova, GastroPlus software product manager and Team Leader for Simulation Technologies, said: “This latest release of GastroPlus adds several important improvements to the PBPKPlusTM and PDPlusTM add-on modules as well as many convenience features for our users. The number of improvements is significant, but most of the details are quite technical. For the purposes of this press release, we’ll simply say that some new features provide greater accuracy for certain types of simulations, while other new features allow users to generate and visualize simulation results in more convenient ways. The entire purpose is, of course, to provide increased quality and quantity of information to our users to allow them to make better project decisions.”
Ron Creeley, vice president of marketing and sales for Simulations Plus, added: “GastroPlus has become the gold standard for its type of software, and we’re now getting reports from the field that GastroPlus simulation results are becoming required in many of their internal project reports. It continues to provide the highest revenues of all of our software products, and it is the basis for the majority of our consulting contracts.”
About Simulations Plus, Inc.
Simulations Plus, Inc., is a premier developer of groundbreaking drug discovery and development simulation and modeling software, which is licensed to and used in the conduct of drug research by major pharmaceutical and biotechnology companies worldwide. The Company has two other businesses, Words+, Inc. and FutureLab™, which are based on its proprietary software technologies. Simulations Plus, Inc., is headquartered in Southern California. For more information, visit our Web site at www.simulations-plus.com.
